Vertex Pharmaceuticals Company Profile (NASDAQ:VRTX)

About Vertex Pharmaceuticals

Vertex Pharmaceuticals logoVertex Pharmaceuticals Incorporated is engaged in the business of discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company operates in pharmaceuticals segment. Its business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Its marketed medicines are ORKAMBI and KALYDECO, which are approved to treat patients with CF having specific mutations in their CF transmembrane conductance regulator (CFTR) gene. It has multiple development programs in the field of CF, including VX-661, VX-371, and VX-152 and VX-440. It is engaged in various other research and mid- and early-stage development programs, such as programs in the areas of oncology, pain and neurology. Its oncology drug candidates include VX-970, VX-803 and VX-984; pain drug candidates include VX-150 and VX-241, and acute spinal cord injury drug candidate include VX-210.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: VRTX
  • CUSIP: 92532F10
Key Metrics:
  • Previous Close: $96.38
  • 50 Day Moving Average: $96.38
  • 200 Day Moving Average: $88.53
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 61.84
  • P/E Growth: 1.74
  • Market Cap: $24.06B
  • Outstanding Shares: 247,778,000
  • Beta: 0.56
Additional Links:
Companies Related to Vertex Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) (?)
Ratings Breakdown: 7 Hold Ratings, 17 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $122.85 (26.53% upside)

Analysts' Ratings History for Vertex Pharmaceuticals (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016Robert W. BairdReiterated RatingOutperform$128.00View Rating Details
8/16/2016Jefferies GroupReiterated RatingBuy$107.00View Rating Details
8/16/2016RBC Capital MarketsReiterated RatingBuyView Rating Details
8/16/2016JMP SecuritiesReiterated RatingBuyView Rating Details
8/16/2016Maxim GroupReiterated RatingHoldView Rating Details
8/16/2016Stifel NicolausLower Price TargetBuy$108.00 -> $105.00View Rating Details
8/15/2016Leerink SwannReiterated RatingOutperform$113.00View Rating Details
7/31/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
7/28/2016Cowen and CompanyReiterated RatingHoldView Rating Details
7/28/2016Morgan StanleyLower Price TargetOverweight$140.00 -> $139.00View Rating Details
6/18/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
6/16/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
4/28/2016Needham & Company LLCReiterated RatingHoldView Rating Details
4/28/2016HC WainwrightReiterated RatingBuy$155.00View Rating Details
4/28/2016Barclays PLCLower Price TargetOverweight$135.00 -> $110.00View Rating Details
4/28/2016Goldman Sachs Group Inc.DowngradeBuy -> Neutral$109.00 -> $88.00View Rating Details
4/28/2016Royal Bank Of CanadaLower Price TargetOutperform$135.00 -> $115.00View Rating Details
4/7/2016BMO Capital MarketsInitiated CoverageMarket Perform$90.00View Rating Details
3/28/2016GuggenheimLower Price TargetBuy$145.00 -> $114.00View Rating Details
3/15/2016Bank of America Corp.Reiterated RatingNeutral$108.00View Rating Details
2/11/2016Oppenheimer Holdings Inc.Initiated CoverageMarket PerformView Rating Details
2/4/2016ArgusLower Price TargetBuy$154.00 -> $140.00View Rating Details
10/27/2015William BlairReiterated RatingBuy$158.00View Rating Details
9/15/2015NomuraInitiated CoverageBuy$162.00View Rating Details
7/31/2015Deutsche Bank AGReiterated RatingBuy$155.00View Rating Details
7/7/2015BTIG ResearchLower Price TargetBuy$200.00 -> $180.00View Rating Details
6/5/2015Canaccord GenuityReiterated RatingBuy$150.00View Rating Details
4/30/2015Citigroup Inc.Boost Price TargetBuy$141.00 -> $156.00View Rating Details
1/9/2015Janney Montgomery ScottInitiated CoverageNeutral$126.00View Rating Details
11/5/2014CRT CapitalInitiated CoverageBuy$175.00View Rating Details
10/13/2014Wells Fargo & Co.UpgradeNeutral -> Outperform$129.00 -> $125.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Vertex Pharmaceuticals (NASDAQ:VRTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2016        
7/27/2016Q216$0.21$0.24$428.08 million$431.61 millionViewListenView Earnings Details
4/27/2016Q116$0.29$0.09$439.94 million$398.10 millionViewListenView Earnings Details
1/27/2016Q4$0.17$0.17$406.30 million$417.94 millionViewListenView Earnings Details
10/28/2015Q315($0.60)($0.13)$245.84 million$309.82 millionViewListenView Earnings Details
7/29/2015Q215($0.58)($0.54)$149.49 million$166.00 millionViewListenView Earnings Details
4/29/2015Q115($0.75)($0.62)$142.38 million$138.51 millionViewListenView Earnings Details
1/28/2015Q414($0.65)($0.55)$137.50 million$144.56 millionViewListenView Earnings Details
10/28/2014Q314($0.62)($0.37)$146.20 million$179.00 millionViewN/AView Earnings Details
7/29/2014Q214($0.71)($0.61)$131.85 million$138.42 millionViewListenView Earnings Details
5/1/2014Q114($0.68)($0.65)$134.46 million$118.50 millionViewN/AView Earnings Details
1/29/2014Q413($0.49)($0.56)$221.08 million$351.20 millionViewListenView Earnings Details
10/29/2013Q413($0.33)($0.32)$278.80 million$222.00 millionViewN/AView Earnings Details
7/29/2013Q2 2013($0.18)($0.26)$308.02 million$310.80 millionViewN/AView Earnings Details
4/30/2013Q1 2013($0.06)$0.03$307.85 million$328.40 millionViewN/AView Earnings Details
1/29/2013Q4 2012($0.07)($0.35)$318.53 million$334.00 millionViewN/AView Earnings Details
11/1/2012Q312$0.34$0.13$377.14 million$336.00 millionViewN/AView Earnings Details
7/30/2012$0.68$0.46ViewN/AView Earnings Details
4/26/2012$0.57$0.43ViewN/AView Earnings Details
2/2/2012$0.76$0.74ViewN/AView Earnings Details
10/27/2011$0.17$0.70ViewN/AView Earnings Details
7/28/2011($1.00)($0.67)ViewN/AView Earnings Details
5/3/2011($1.09)($0.91)ViewN/AView Earnings Details
2/3/2011($0.93)($0.74)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vertex Pharmaceuticals (NASDAQ:VRTX)
Current Year EPS Consensus Estimate: $-0.02 EPS
Next Year EPS Consensus Estimate: $1.57 EPS

Dividends

Dividend History for Vertex Pharmaceuticals (NASDAQ:VRTX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/29/2013quarterly$0.402/20/20133/13/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Vertex Pharmaceuticals (NASDAQ:VRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/24/2016Joshua S BogerDirectorSell7,500$100.46$753,450.00View SEC Filing  
8/22/2016Joshua S BogerDirectorSell1,100$100.79$110,869.00View SEC Filing  
8/17/2016Joshua S BogerDirectorSell6,900$99.63$687,447.00View SEC Filing  
8/11/2016Joshua S BogerDirectorSell900$100.19$90,171.00View SEC Filing  
8/10/2016Joshua S BogerDirectorSell7,100$100.24$711,704.00View SEC Filing  
8/3/2016Joshua S BogerDirectorSell47,000$100.66$4,731,020.00View SEC Filing  
7/27/2016Joshua S BogerDirectorSell6,500$95.93$623,545.00View SEC Filing  
7/20/2016Joshua S BogerDirectorSell6,500$90.33$587,145.00View SEC Filing  
7/13/2016Joshua S BogerDirectorSell6,500$88.81$577,265.00View SEC Filing  
7/6/2016Joshua S BogerDirectorSell5,140$88.99$457,408.60View SEC Filing  
6/29/2016Joshua S BogerDirectorSell5,130$84.82$435,126.60View SEC Filing  
6/22/2016Joshua S BogerDirectorSell5,130$86.61$444,309.30View SEC Filing  
6/15/2016Joshua S BogerDirectorSell5,130$91.18$467,753.40View SEC Filing  
6/8/2016Joshua S BogerDirectorSell5,130$94.95$487,093.50View SEC Filing  
6/1/2016Joshua S BogerDirectorSell5,130$93.65$480,424.50View SEC Filing  
5/25/2016Joshua S BogerDirectorSell5,130$89.09$457,031.70View SEC Filing  
5/18/2016Joshua S BogerDirectorSell5,130$81.18$416,453.40View SEC Filing  
5/16/2016Amit SachdevEVPSell117$81.67$9,555.39View SEC Filing  
5/16/2016Ian F SmithCFOSell202$82.06$16,576.12View SEC Filing  
5/11/2016Joshua S BogerDirectorSell5,130$86.50$443,745.00View SEC Filing  
5/9/2016Paul M SilvaSVPSell3,000$87.63$262,890.00View SEC Filing  
5/4/2016Joshua S BogerDirectorSell5,130$81.02$415,632.60View SEC Filing  
4/27/2016Joshua S BogerDirectorSell5,130$83.67$429,227.10View SEC Filing  
4/20/2016Joshua S BogerDirectorSell5,130$84.10$431,433.00View SEC Filing  
4/13/2016Joshua S BogerDirectorSell5,130$84.27$432,305.10View SEC Filing  
4/6/2016Joshua S BogerDirectorSell5,130$89.56$459,442.80View SEC Filing  
3/30/2016Joshua S BogerDirectorSell5,130$78.83$404,397.90View SEC Filing  
3/23/2016Joshua S BogerDirectorSell5,130$81.38$417,479.40View SEC Filing  
3/16/2016Joshua S BogerDirectorSell5,130$79.65$408,604.50View SEC Filing  
3/2/2016Joshua S BogerDirectorSell5,130$91.80$470,934.00View SEC Filing  
2/24/2016Joshua S BogerDirectorSell5,130$85.25$437,332.50View SEC Filing  
2/17/2016Joshua S. BogerDirectorSell5,130$86.93$445,950.90View SEC Filing  
2/10/2016Joshua S. BogerDirectorSell5,130$82.57$423,584.10View SEC Filing  
2/3/2016Ian F. SmithCFOSell12,084$90.84$1,097,710.56View SEC Filing  
2/3/2016Jeffrey M. LeidenCEOSell9,834$90.82$893,123.88View SEC Filing  
2/3/2016Joshua S. BogerDirectorSell5,130$90.81$465,855.30View SEC Filing  
2/3/2016Paul M. SilvaSVPSell5,062$90.82$459,730.84View SEC Filing  
2/3/2016Stuart A. ArbuckleEVPSell6,042$90.82$548,734.44View SEC Filing  
2/2/2016Jeffrey ChodakewitzCMOSell2,375$91.38$217,027.50View SEC Filing  
1/27/2016Joshua S. BogerDirectorSell11,200$93.22$1,044,064.00View SEC Filing  
1/20/2016Joshua S. BogerDirectorSell10,400$93.69$974,376.00View SEC Filing  
1/13/2016Joshua S. BogerDirectorSell10,400$98.41$1,023,464.00View SEC Filing  
1/6/2016Joshua S. BogerDirectorSell10,400$121.96$1,268,384.00View SEC Filing  
1/4/2016Yuchun LeeDirectorSell1,125$122.21$137,486.25View SEC Filing  
12/30/2015Joshua S. BogerDirectorSell10,400$127.15$1,322,360.00View SEC Filing  
12/21/2015Joshua S. BogerDirectorSell10,400$119.26$1,240,304.00View SEC Filing  
12/9/2015Joshua S. BogerDirectorSell10,400$120.80$1,256,320.00View SEC Filing  
12/4/2015Stuart A. ArbuckleEVPSell4,531$123.98$561,753.38View SEC Filing  
12/2/2015Joshua S. BogerDirectorSell10,400$130.91$1,361,464.00View SEC Filing  
12/1/2015David AltshulerEVPSell5,000$131.00$655,000.00View SEC Filing  
12/1/2015Yuchun LeeDirectorSell1,125$129.65$145,856.25View SEC Filing  
11/23/2015Joshua S. BogerDirectorSell10,400$132.18$1,374,672.00View SEC Filing  
11/11/2015Joshua S. BogerDirectorSell10,400$118.59$1,233,336.00View SEC Filing  
11/4/2015Joshua S. BogerDirectorSell10,400$124.23$1,291,992.00View SEC Filing  
11/2/2015Yuchun LeeDirectorSell1,125$126.19$141,963.75View SEC Filing  
10/28/2015Joshua S. BogerDirectorSell10,400$119.01$1,237,704.00View SEC Filing  
10/21/2015Joshua S. BogerDirectorSell10,400$108.82$1,131,728.00View SEC Filing  
10/14/2015Joshua S. BogerDirectorSell10,400$112.62$1,171,248.00View SEC Filing  
10/7/2015Joshua S. BogerDirectorSell10,400$109.61$1,139,944.00View SEC Filing  
10/2/2015Elaine UllianDirectorSell20,000$110.00$2,200,000.00View SEC Filing  
10/1/2015Stuart A. ArbuckleEVPSell12,417$104.71$1,300,184.07View SEC Filing  
10/1/2015Yuchun LeeDirectorSell1,125$104.64$117,720.00View SEC Filing  
9/30/2015Joshua S. BogerDirectorSell10,400$103.14$1,072,656.00View SEC Filing  
9/23/2015Joshua S. BogerDirectorSell10,400$111.89$1,163,656.00View SEC Filing  
9/16/2015Joshua S. BogerDirectorSell10,400$133.24$1,385,696.00View SEC Filing  
9/9/2015Joshua S. BogerDirectorSell10,400$131.41$1,366,664.00View SEC Filing  
9/4/2015Stuart A. ArbuckleEVPSell9,063$125.77$1,139,853.51View SEC Filing  
9/2/2015Joshua S. BogerDirectorSell10,400$125.85$1,308,840.00View SEC Filing  
9/1/2015Yuchun LeeDirectorSell1,125$125.40$141,075.00View SEC Filing  
8/26/2015Joshua S. BogerDirectorSell10,400$124.71$1,296,984.00View SEC Filing  
8/19/2015Joshua S. BogerDirectorSell10,400$139.93$1,455,272.00View SEC Filing  
8/12/2015Joshua S BogerDirectorSell10,400$135.83$1,412,632.00View SEC Filing  
7/22/2015Joshua S BogerDirectorSell10,400$130.92$1,361,568.00View SEC Filing  
7/15/2015Joshua S BogerDirectorSell12,200$133.98$1,634,556.00View SEC Filing  
7/13/2015Paul M SilvaSVPSell1,125$123.79$139,263.75View SEC Filing  
7/8/2015Joshua S BogerDirectorSell11,700$122.74$1,436,058.00View SEC Filing  
7/2/2015Jeffrey ChodakewitzCMOSell2,291$129.36$296,363.76View SEC Filing  
7/1/2015Joshua S BogerDirectorSell11,700$125.60$1,469,520.00View SEC Filing  
6/24/2015Joshua S BogerDirectorSell11,700$130.41$1,525,797.00View SEC Filing  
6/17/2015Joshua S BogerDirectorSell11,700$123.90$1,449,630.00View SEC Filing  
6/10/2015Joshua S BogerDirectorSell11,700$125.02$1,462,734.00View SEC Filing  
5/20/2015Joshua S BogerDirectorSell11,700$126.73$1,482,741.00View SEC Filing  
5/6/2015Joshua S BogerDirectorSell11,700$122.79$1,436,643.00View SEC Filing  
5/5/2015Paul M SilvaSVPSell4,101$123.68$507,211.68View SEC Filing  
4/29/2015Joshua S BogerDirectorSell11,700$124.59$1,457,703.00View SEC Filing  
4/27/2015Paul M SilvaSVPSell1,125$129.74$145,957.50View SEC Filing  
4/27/2015Stuart A ArbuckleEVPSell61,480$129.36$7,953,052.80View SEC Filing  
4/27/2015Terrence C KearneyDirectorSell68,125$129.11$8,795,618.75View SEC Filing  
4/22/2015Joshua S BogerDirectorSell11,700$132.46$1,549,782.00View SEC Filing  
4/15/2015Joshua S BogerDirectorSell11,700$129.25$1,512,225.00View SEC Filing  
4/13/2015Paul M SilvaSVPSell1,125$128.60$144,675.00View SEC Filing  
4/8/2015Joshua S BogerDirectorSell11,700$123.26$1,442,142.00View SEC Filing  
4/6/2015Margaret G McglynnDirectorSell12,500$118.36$1,479,500.00View SEC Filing  
4/2/2015Jeffrey ChodakewitzCMOSell2,291$115.50$264,610.50View SEC Filing  
4/1/2015Joshua S BogerDirectorSell11,700$115.87$1,355,679.00View SEC Filing  
3/25/2015Joshua S BogerDirectorSell11,700$120.76$1,412,892.00View SEC Filing  
3/23/2015Amit SachdevEVPSell17,083$132.28$2,259,739.24View SEC Filing  
3/23/2015Ian F SmithCFOSell6,042$125.67$759,298.14View SEC Filing  
3/23/2015Paul M SilvaSVPSell2,250$125.65$282,712.50View SEC Filing  
3/18/2015Amit SachdevEVPSell12,000$130.00$1,560,000.00View SEC Filing  
2/5/2015Paul M SilvaSVPSell1,688$109.75$185,258.00View SEC Filing  
2/4/2015Joshua S BogerDirectorSell5,700$108.81$620,217.00View SEC Filing  
2/3/2015Paul M SilvaSVPSell2,063$108.89$224,640.07View SEC Filing  
2/2/2015Jeffrey ChodakewitzCMOSell1,188$109.60$130,204.80View SEC Filing  
1/28/2015Joshua S BogerDirectorSell10,688$122.78$1,312,272.64View SEC Filing  
1/26/2015Paul M SilvaSVPSell1,125$125.62$141,322.50View SEC Filing  
1/21/2015Joshua S BogerDirectorSell10,500$125.08$1,313,340.00View SEC Filing  
1/14/2015Joshua S BogerDirectorSell10,500$120.16$1,261,680.00View SEC Filing  
1/9/2015Amit SachdevEVPSell12,000$125.00$1,500,000.00View SEC Filing  
1/9/2015Bruce I SachsDirectorSell9,861$125.04$1,233,019.44View SEC Filing  
1/7/2015Joshua S BogerDirectorSell10,500$119.32$1,252,860.00View SEC Filing  
1/2/2015Jeffrey ChodakewitzCMOSell2,291$122.54$280,739.14View SEC Filing  
12/22/2014Joshua S BogerDirectorSell10,500$117.65$1,235,325.00View SEC Filing  
12/17/2014Joshua S BogerDirectorSell10,500$110.66$1,161,930.00View SEC Filing  
12/15/2014Jeffrey M LeidenCEOSell50,017$114.97$5,750,454.49View SEC Filing  
12/12/2014Paul M SilvaSVPSell2,813$120.08$337,785.04View SEC Filing  
11/28/2014Amit SachdevEVPSell12,000$120.00$1,440,000.00View SEC Filing  
11/28/2014Bruce I SachsDirectorSell10,000$120.03$1,200,300.00View SEC Filing  
11/28/2014Paul M SilvaSVPSell8,164$119.85$978,455.40View SEC Filing  
11/26/2014Joshua S BogerDirectorSell10,500$114.54$1,202,670.00View SEC Filing  
11/6/2014Bruce I SachsDirectorSell9,900$115.21$1,140,579.00View SEC Filing  
11/5/2014Bruce I SachsDirectorSell30,100$112.62$3,389,862.00View SEC Filing  
11/3/2014Joshua S BogerDirectorSell127,411$112.20$14,295,514.20View SEC Filing  
10/29/2014Joshua S BogerDirectorSell10,500$109.44$1,149,120.00View SEC Filing  
10/28/2014Amit SachdevEVPSell12,000$115.00$1,380,000.00View SEC Filing  
10/28/2014David AltshulerDirectorSell2,000$114.75$229,500.00View SEC Filing  
10/28/2014Jeffrey ChodakewitzCMOSell3,438$115.00$395,370.00View SEC Filing  
10/27/2014Paul M SilvaSVPSell1,125$110.03$123,783.75View SEC Filing  
10/13/2014Paul M SilvaSVPSell1,125$107.89$121,376.25View SEC Filing  
10/7/2014Jeffrey ChodakewitzCMOSell3,436$104.26$358,237.36View SEC Filing  
10/6/2014David AltshulerDirectorSell1,405$109.75$154,198.75View SEC Filing  
10/1/2014Elaine UllianDirectorSell5,000$107.74$538,700.00View SEC Filing  
10/1/2014Stuart A ArbuckleEVPSell12,417$107.71$1,337,435.07View SEC Filing  
9/30/2014Amit SachdevSVPSell86,000$112.68$9,690,480.00View SEC Filing  
9/30/2014Ian F SmithCFOSell108,026$112.68$12,172,369.68View SEC Filing  
9/30/2014Jeffrey M LeidenCEOSell200,000$112.69$22,538,000.00View SEC Filing  
9/30/2014Kenneth L HortonEVPSell36,000$112.69$4,056,840.00View SEC Filing  
9/29/2014David AltshulerDirectorSell2,500$114.75$286,875.00View SEC Filing  
9/24/2014Joshua S BogerDirectorSell5,200$109.21$567,892.00View SEC Filing  
9/19/2014David AltshulerDirectorSell5,000$102.25$511,250.00View SEC Filing  
9/19/2014Paul M SilvaSVPSell25,408$99.85$2,536,988.80View SEC Filing  
9/19/2014Stuart A ArbuckleEVPSell55,521$100.00$5,552,100.00View SEC Filing  
9/17/2014Joshua S BogerDirectorSell5,200$93.62$486,824.00View SEC Filing  
9/10/2014Joshua S BogerDirectorSell5,200$94.42$490,984.00View SEC Filing  
9/5/2014David AltshulerDirectorSell2,500$94.75$236,875.00View SEC Filing  
9/3/2014Joshua S BogerDirectorSell5,200$92.79$482,508.00View SEC Filing  
8/27/2014Joshua S BogerDirectorSell5,200$93.31$485,212.00View SEC Filing  
8/20/2014Joshua S BogerDirectorSell5,200$91.51$475,852.00View SEC Filing  
8/13/2014Joshua S BogerDirectorSell5,200$88.00$457,600.00View SEC Filing  
8/6/2014Joshua S BogerDirectorSell5,200$86.54$450,008.00View SEC Filing  
7/31/2014David AltshulerDirectorSell5,000$89.59$447,950.00View SEC Filing  
7/31/2014Paul M SilvaSVPSell2,027$88.97$180,342.19View SEC Filing  
7/30/2014Joshua S BogerDirectorSell5,200$92.17$479,284.00View SEC Filing  
7/15/2014Wayne Joseph RileyDirectorSell4,800$96.65$463,920.00View SEC Filing  
7/1/2014Elaine UllianDirectorSell5,000$95.21$476,050.00View SEC Filing  
7/1/2014Kenneth L HortonEVPSell30,134$95.22$2,869,359.48View SEC Filing  
6/24/2014Megan E PaceSVPSell12,734$98.03$1,248,314.02View SEC Filing  
6/24/2014Wayne Joseph RileyDirectorSell15,000$98.03$1,470,450.00View SEC Filing  
6/16/2014Peter MuellerEVPSell7,500$68.31$512,325.00View SEC Filing  
6/9/2014Elaine UllianDirectorSell2,500$75.00$187,500.00View SEC Filing  
5/14/2014Peter MuellerEVPSell7,500$67.45$505,875.00View SEC Filing  
5/2/2014Megan PaceSVPSell1,000$67.62$67,620.00View SEC Filing  
4/15/2014Peter MuellerEVPSell7,500$61.63$462,225.00View SEC Filing  
4/9/2014Elaine UllianDirectorSell2,500$70.00$175,000.00View SEC Filing  
3/21/2014Bruce SachsDirectorSell8,700$74.59$648,933.00View SEC Filing  
3/17/2014Peter MuellerEVPSell7,500$78.29$587,175.00View SEC Filing  
2/7/2014Jeffrey LeidenCEOSell35,944$80.00$2,875,520.00View SEC Filing  
1/22/2014Bruce SachsDirectorSell8,300$84.47$701,101.00View SEC Filing  
1/21/2014Megan PaceSVPSell1,250$85.00$106,250.00View SEC Filing  
1/16/2014Jeffrey LeidenCEOSell45,000$80.00$3,600,000.00View SEC Filing  
1/15/2014Peter MuellerEVPSell7,500$78.67$590,025.00View SEC Filing  
12/23/2013Bruce SachsDirectorSell8,300$73.02$606,066.00View SEC Filing  
12/16/2013Peter MuellerEVPSell7,500$64.69$485,175.00View SEC Filing  
12/12/2013Jeffrey LeidenCEOSell9,834$65.48$643,930.32View SEC Filing  
12/12/2013Kenneth HortonEVPSell4,532$65.46$296,664.72View SEC Filing  
12/12/2013Megan PaceSVPSell5,083$65.48$332,834.84View SEC Filing  
12/4/2013Joshua BogerDirectorSell1,400$67.48$94,472.00View SEC Filing  
11/25/2013Joshua BogerDirectorSell1,400$66.89$93,646.00View SEC Filing  
11/20/2013Bruce SachsDirectorSell8,300$65.28$541,824.00View SEC Filing  
11/19/2013Joshua BogerDirectorSell1,400$62.31$87,234.00View SEC Filing  
11/5/2013Joshua BogerDirectorSell1,400$65.64$91,896.00View SEC Filing  
10/29/2013Joshua S BogerDirectorSell1,400$75.42$105,588.00View SEC Filing  
10/29/2013Thomas ConnollySVPSell1,688$75.04$126,667.52View SEC Filing  
10/24/2013Bruce I SachsDirectorSell8,300$77.06$639,598.00View SEC Filing  
10/23/2013Joshua S BogerDirectorSell1,400$76.77$107,478.00View SEC Filing  
10/16/2013Joshua S BogerDirectorSell1,400$75.41$105,574.00View SEC Filing  
10/15/2013Peter MuellerEVPSell7,500$73.25$549,375.00View SEC Filing  
10/14/2013Paul SilvaSVPSell1,593$71.87$114,488.91View SEC Filing  
10/9/2013Joshua BogerDirectorSell1,400$72.35$101,290.00View SEC Filing  
9/25/2013Joshua BogerDirectorSell1,400$74.72$104,608.00View SEC Filing  
9/18/2013Joshua BogerDirectorSell1,400$77.43$108,402.00View SEC Filing  
9/16/2013Peter MuellerEVPSell7,500$77.22$579,150.00View SEC Filing  
9/11/2013Joshua BogerDirectorSell1,400$79.61$111,454.00View SEC Filing  
9/4/2013Joshua BogerDirectorSell1,400$75.45$105,630.00View SEC Filing  
8/29/2013Bruce SachsDirectorSell8,300$77.19$640,677.00View SEC Filing  
8/28/2013Joshua BogerDirectorSell1,400$76.24$106,736.00View SEC Filing  
8/21/2013Joshua BogerDirectorSell1,400$76.96$107,744.00View SEC Filing  
8/15/2013Peter MuellerEVPSell7,500$77.41$580,575.00View SEC Filing  
8/14/2013Joshua BogerDirectorSell1,400$77.18$108,052.00View SEC Filing  
8/7/2013Joshua BogerDirectorSell1,400$77.84$108,976.00View SEC Filing  
8/5/2013Paul SilvaSVPSell3,001$78.90$236,778.90View SEC Filing  
7/31/2013Joshua S BogerDirectorSell1,400$80.89$113,246.00View SEC Filing  
7/29/2013Wayne Joseph RileyDirectorSell9,800$80.09$784,882.00View SEC Filing  
7/25/2013Paul M SilvaSVPSell1,125$86.49$97,301.25View SEC Filing  
7/24/2013Bruce I SachsDirectorSell8,300$85.50$709,650.00View SEC Filing  
7/19/2013Amit SachdevSVPSell22,250$88.69$1,973,352.50View SEC Filing  
7/18/2013Joshua S BogerDirectorSell1,400$86.12$120,568.00View SEC Filing  
7/16/2013Paul M SilvaSVPSell2,063$86.25$177,933.75View SEC Filing  
7/15/2013Christiana StamoulisSVPSell1,125$86.35$97,143.75View SEC Filing  
7/15/2013Peter MuellerEVPSell7,500$86.34$647,550.00View SEC Filing  
7/12/2013Megan E PaceSVPSell10,678$85.00$907,630.00View SEC Filing  
7/11/2013Joshua S BogerDirectorSell1,400$83.83$117,362.00View SEC Filing  
7/8/2013Kenneth L HortonEVPSell1,813$80.72$146,345.36View SEC Filing  
7/8/2013Megan E PaceSVPSell28,703$80.89$2,321,785.67View SEC Filing  
7/5/2013Christiana StamoulisSVPSell4,687$81.21$380,631.27View SEC Filing  
7/3/2013Joshua S BogerDirectorSell1,400$80.20$112,280.00View SEC Filing  
7/2/2013Peter MuellerEVPSell122,300$79.80$9,759,540.00View SEC Filing  
6/26/2013Joshua S BogerDirectorSell1,400$78.59$110,026.00View SEC Filing  
6/21/2013Bruce I SachsDirectorSell8,300$75.93$630,219.00View SEC Filing  
6/19/2013Joshua S BogerDirectorSell1,400$79.11$110,754.00View SEC Filing  
6/12/2013Joshua S BogerDirectorSell1,400$81.19$113,666.00View SEC Filing  
6/5/2013Joshua S BogerDirectorSell1,400$77.15$108,010.00View SEC Filing  
5/30/2013Joshua S BogerDirectorSell1,400$82.47$115,458.00View SEC Filing  
5/22/2013Joshua S BogerDirectorSell1,400$79.72$111,608.00View SEC Filing  
5/15/2013Joshua S BogerDirectorSell1,400$79.36$111,104.00View SEC Filing  
5/14/2013Bruce I SachsDirectorSell60,000$81.15$4,869,000.00View SEC Filing  
12/26/2012Joshua S BogerDirectorSell4,000$41.86$167,440.00View SEC Filing  
11/7/2012Margaret G McglynnDirectorBuy1,000$45.50$45,500.00View SEC Filing  
10/8/2012Ian F SmithCFOSell44,787$60.00$2,687,220.00View SEC Filing  
10/3/2012Joshua S BogerDirectorSell4,000$57.74$230,960.00View SEC Filing  
9/5/2012Joshua S BogerDirectorSell4,000$54.70$218,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vertex Pharmaceuticals (NASDAQ:VRTX)
DateHeadline
fidaily.com logoInsiders Are Selling – Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX) (NASDAQ:VRTX)
www.fidaily.com - August 26 at 7:45 PM
News IconShares Moving Higher for the Quarter: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (NASDAQ:VRTX)
magseriesusa.net - August 26 at 11:01 AM
finance.yahoo.com logoBiotech's next big deal? (NASDAQ:VRTX)
finance.yahoo.com - August 22 at 8:05 PM
News IconAnalysts Valuations For Two Stocks: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Xilinx, Inc. (NASDAQ:XLNX) - The Voice Registrar (NASDAQ:VRTX)
voiceregistrar.com - August 18 at 8:24 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen (NASDAQ:VRTX)
finance.yahoo.com - August 18 at 11:18 AM
News IconVertex Dumps Phase III Cystic Fibrosis Study (NASDAQ:VRTX)
www.pharmalive.com - August 16 at 8:15 PM
rttnews.com logoVertex Pharmaceuticals Inc. (VRTX) Is Losing Ground After VX-661 Update (NASDAQ:VRTX)
www.rttnews.com - August 16 at 11:32 AM
investors.com logoVertex Stock Slips On Drug Trial Failure, Though Not A Surprise (NASDAQ:VRTX)
www.investors.com - August 16 at 11:32 AM
finance.yahoo.com logoVertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down (NASDAQ:VRTX)
finance.yahoo.com - August 16 at 11:32 AM
rttnews.com logoVertex Pharmaceuticals Inc. (VRTX) Is Losing Ground After VX-661 Update - RTT News (NASDAQ:VRTX)
www.rttnews.com - August 15 at 8:33 PM
finance.yahoo.com logo4:07 pm Vertex Pharma updates on its Phase 3 development program of its VX-661 in combination with ivacaftor; plans to stop the study of VX-661 and ivacaftor in people with one copy of the F508del mutation after DSMB review (NASDAQ:VRTX)
finance.yahoo.com - August 15 at 8:33 PM
publicnow.com logoVertex Provides Update on Ongoing Phase 3 Program for VX-661 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis (NASDAQ:VRTX)
www.publicnow.com - August 15 at 8:33 PM
cnbc.com logoAfter-hours buzz: HAIN, FN, VRTX & more (NASDAQ:VRTX)
www.cnbc.com - August 15 at 8:33 PM
feeds.benzinga.com logoVertex Pharmaceuticals' Phase 3 Studies Offer Ample Opportunity For Upside (NASDAQ:VRTX)
feeds.benzinga.com - August 15 at 4:27 PM
News IconRhenman Partners Asset Management Ab Lowers stake in Vertex Pharmaceuticals Incorporated (VRTX) (NASDAQ:VRTX)
myhealthbowl.com - August 11 at 11:39 AM
fool.com logoThese 2 Catalysts Lifted Vertex Pharmaceuticals Incorporated 13% in July (NASDAQ:VRTX)
www.fool.com - August 10 at 12:25 PM
sg.finance.yahoo.com logoAstraZeneca bets another $140 million on Moderna's 'messenger' drugs (NASDAQ:VRTX)
sg.finance.yahoo.com - August 10 at 11:26 AM
News IconActive biotech company shares in the news: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology ... - The Voice Registrar (NASDAQ:VRTX)
voiceregistrar.com - August 9 at 8:32 PM
blogs.barrons.com logoBiotech Stocks: Blame Gilead? (NASDAQ:VRTX)
blogs.barrons.com - August 9 at 11:39 AM
fortune.com logoNotable Research Reports: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Regeneron Pharmaceuticals Inc ... - Review Fortune (NASDAQ:VRTX)
reviewfortune.com - August 8 at 8:23 PM
finance.yahoo.com logoVERTEX PHARMACEUTICALS INC / MA Financials (NASDAQ:VRTX)
finance.yahoo.com - August 6 at 8:03 PM
capitalcube.com logoVertex Pharmaceuticals, Inc. :VRTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:VRTX)
www.capitalcube.com - August 3 at 8:34 PM
News IconVertex Pharmaceuticals Inc. (VRTX) Posts Earnings Results, Beats Expectations By $0.03 EPS (NASDAQ:VRTX)
bolsafinanzas.com - August 2 at 8:36 PM
blogs.barrons.com logo'We Can Get as High as $475′: Biogen Soars on Takeover Speculation; What About Celgene, BioMarin? (NASDAQ:VRTX)
blogs.barrons.com - August 2 at 8:36 PM
biz.yahoo.com logoVERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report (NASDAQ:VRTX)
biz.yahoo.com - August 1 at 7:56 PM
finance.yahoo.com logoWill the biotech rally will continue? (NASDAQ:VRTX)
finance.yahoo.com - August 1 at 7:56 PM
News IconHC Stocks Watchful: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), IDEXX Laboratories, Inc. (NASDAQ:IDXX) - share market updates (press release) (NASDAQ:VRTX)
sharemarketupdates.com - July 29 at 11:14 AM
News IconStocks Preparing To Gain Concentrations- Vertex Pharmaceuticals ... - Seneca Globe (NASDAQ:VRTX)
www.senecaglobe.com - July 28 at 8:38 PM
smarteranalyst.com logoStock Update (NYSE:VRTX): Vertex Pharmaceuticals Incorporated Announces Second Quarter 2016 Financial Results - Smarter Analyst (NASDAQ:VRTX)
www.smarteranalyst.com - July 28 at 11:34 AM
finance.yahoo.com logoVertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short (NASDAQ:VRTX)
finance.yahoo.com - July 28 at 7:13 AM
finance.yahoo.com logoEdited Transcript of VRTX earnings conference call or presentation 27-Jul-16 8:30pm GMT (NASDAQ:VRTX)
finance.yahoo.com - July 28 at 2:41 AM
nasdaq.com logoEarnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.7% Sensitive (NASDAQ:VRTX)
www.nasdaq.com - July 27 at 8:39 PM
rttnews.com logoEARNINGS SUMMARY: Details of Vertex Pharmaceuticals Inc. Q2 Earnings Report (NASDAQ:VRTX)
www.rttnews.com - July 27 at 8:39 PM
cnbc.com logoVertex reports 2Q loss (NASDAQ:VRTX)
www.cnbc.com - July 27 at 8:39 PM
News IconVertex Pharmaceuticals reports 2Q loss (NASDAQ:VRTX)
www.sfgate.com - July 27 at 8:39 PM
biz.yahoo.com logoQ2 2016 Vertex Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:VRTX)
biz.yahoo.com - July 27 at 7:07 AM
finance.yahoo.com logo5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More (NASDAQ:VRTX)
finance.yahoo.com - July 26 at 10:36 AM
News IconShares of Vertex Pharmaceuticals Incorporated (VRTX) Sees Large Outflow of Money (NASDAQ:VRTX)
lovingfutbol.com - July 22 at 8:00 PM
marketrealist.com logoWhy Has the JPMorgan Large-Cap Growth Fund Done so Poorly in 2016? (NASDAQ:VRTX)
marketrealist.com - July 22 at 7:55 PM
marketrealist.com logoHow Much Will Orkambi Fetch for Vertex Pharmaceuticals in 2Q16? (NASDAQ:VRTX)
marketrealist.com - July 22 at 1:16 PM
News IconHC Stocks Indications: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), IDEXX Laboratories, Inc. (NASDAQ:IDXX) - share market updates (press release) (NASDAQ:VRTX)
sharemarketupdates.com - July 22 at 11:05 AM
News IconHot Stock under Consideration: Vertex Pharmaceuticals Incorporated (VRTX) (NASDAQ:VRTX)
potiner.com - July 21 at 8:32 PM
marketrealist.com logoWall Street Looks for Vertex Pharmaceuticals to Break Even in 2Q16 (NASDAQ:VRTX)
marketrealist.com - July 21 at 4:43 PM
News IconHealthcare Stock within Investors Radar: BioMarin Pharmaceutical Inc.'s (BMRN) (NASDAQ:VRTX)
bolsafinanzas.com - July 21 at 11:01 AM
forbes.com logoWednesday Sector Leaders: Healthcare, Technology & Communications (NASDAQ:VRTX)
www.forbes.com - July 20 at 9:16 PM
News IconShares of Vertex Pharmaceuticals Incorporated (VRTX) Sees Large Inflow of Net Money Flow - TheFounders Daily (NASDAQ:VRTX)
www.thefoundersdaily.com - July 19 at 8:21 PM
News IconHow Many Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:VRTX)
presstelegraph.com - July 17 at 7:16 AM
capitalcube.com logoVertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : July 15, 2016 (NASDAQ:VRTX)
www.capitalcube.com - July 15 at 8:23 AM
twst.com logoVertex Pharmaceuticals Incorporated: Vertex to Announce Second Quarter 2016 Financial Results on July 27 (NASDAQ:VRTX)
www.twst.com - July 14 at 8:25 PM
4-traders.com logoVertex Pharmaceuticals : to Announce Second Quarter 2016 Financial Results on July 27 (NASDAQ:VRTX)
www.4-traders.com - July 14 at 11:49 AM

Social

Vertex Pharmaceuticals (NASDAQ:VRTX) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff